科拓生物：股东张列兵拟减持不超过500万股

Group 1 - Key Point 1: Kato Bio announced that shareholder Zhang Lieping plans to reduce his holdings by up to 5 million shares, representing approximately 1.8976% of the company's total shares, within three months starting from October 16, 2025 [1] - Key Point 2: Zhang Lieping currently holds about 11 million shares, which accounts for approximately 4.18% of Kato Bio's total share capital [1]